Works matching IS 00223042 AND DT 2023 AND VI 167 AND IP 3

Results: 11

Fundamental Neurochemistry Review: Copper availability as a potential therapeutic target in progressive supranuclear palsy: Insight from other neurodegenerative diseases.

Published in:

Journal of Neurochemistry, 2023, v. 167, n. 3, p. 337, doi. 10.1111/jnc.15978

By:

Billings, Jessica L.;
Hilton, James B. W.;
Liddell, Jeffrey R.;
Hare, Dominic J.;
Crouch, Peter J.

Publication type:

Article

α‐Synuclein induces deficiency in clathrin‐mediated endocytosis through inhibiting synaptojanin1 expression.

Published in:

Journal of Neurochemistry, 2023, v. 167, n. 3, p. 461, doi. 10.1111/jnc.15974

By:

Song, Dong‐Yan;
Yuan, Lin;
Cui, Na;
Feng, Cong;
Meng, Lanxia;
Wang, Xin‐He;
Xiang, Man;
Liu, Di;
Wang, Chun;
Zhang, Zhentao;
Li, Jia‐Yi;
Li, Wen

Publication type:

Article

Effects of anti‐tau immunotherapy on reactive microgliosis, cerebral endotheliopathy, and cognitive function in an experimental model of cerebral malaria.

Published in:

Journal of Neurochemistry, 2023, v. 167, n. 3, p. 441, doi. 10.1111/jnc.15972

By:

Akide Ndunge, Oscar B.;
Shikani, Henry J.;
Dai, Minxian;
Freeman, Brandi D.;
Desruisseaux, Mahalia S.

Publication type:

Article

Strain‐dependent role of copper in prion disease through binding to histidine residues in the N‐terminal domain of prion protein.

Published in:

Journal of Neurochemistry, 2023, v. 167, n. 3, p. 394, doi. 10.1111/jnc.15971

By:

Hara, Hideyuki;
Miyata, Hironori;
Chida, Junji;
Sakaguchi, Suehiro

Publication type:

Article

Dense dopaminergic innervation of the peri‐infarct cortex despite dopaminergic cell loss after a pure motor‐cortical stroke in rats.

Published in:

Journal of Neurochemistry, 2023, v. 167, n. 3, p. 427, doi. 10.1111/jnc.15970

By:

Frase, Sibylle;
Steddin, Julius;
Paschen, Enya;
Lenz, Maximilian;
Conforti, Pasquale;
Haas, Carola A.;
Vlachos, Andreas;
Schachtrup, Christian;
Hosp, Jonas A.

Publication type:

Article

Heme oxygenase‐1: The roles of both good and evil in neurodegenerative diseases.

Published in:

Journal of Neurochemistry, 2023, v. 167, n. 3, p. 347, doi. 10.1111/jnc.15969

By:

Liu, Rong;
Yang, Jiahua;
Li, Yinghui;
Xie, Junxia;
Wang, Jun

Publication type:

Article

Thirty years of BDNF study in central myelination: From biology to therapy.

Published in:

Journal of Neurochemistry, 2023, v. 167, n. 3, p. 321, doi. 10.1111/jnc.15968

By:

Xiao, Junhua

Publication type:

Article

Effects of HMGB1/RAGE/cathespin B inhibitors on alleviating hippocampal injury by regulating microglial pyroptosis and caspase activation in neonatal hypoxic–ischemic brain damage.

Published in:

Journal of Neurochemistry, 2023, v. 167, n. 3, p. 410, doi. 10.1111/jnc.15965

By:

Zhu, Kaiyi;
Zhu, Xing;
Yu, Jie;
Chen, Lu;
Liu, Shiqi;
Yan, Mingjing;
Yang, Wei;
Sun, Yanyan;
Zhang, Zhe;
Li, Jian;
Shen, Tao;
Hei, Mingyan

Publication type:

Article

Plk2 promotes synaptic destabilization through disruption of N‐cadherin adhesion complexes during homeostatic adaptation to hyperexcitation.

Published in:

Journal of Neurochemistry, 2023, v. 167, n. 3, p. 362, doi. 10.1111/jnc.15948

By:

Abdel‐Ghani, Mai;
Lee, Yeunkum;
Akli, Lyna Ait;
Moran, Marielena;
Schneeweis, Amanda;
Djemil, Sarra;
El Choueiry, Rebecca;
Murtadha, Ruqaya;
Pak, Daniel T. S.

Publication type:

Article

Issue Information.

Published in:: Journal of Neurochemistry, 2023, v. 167, n. 3, p. 319, doi. 10.1111/jnc.15643
Publication type:: Article

Tyrosine hydroxylase phosphorylation is under the control of serine 40.

Published in:

Journal of Neurochemistry, 2023, v. 167, n. 3, p. 376, doi. 10.1111/jnc.15963

By:

Stoop, Jesse;
Douma, Erik H.;
van der Vlag, Marc;
Smidt, Marten P.;
van der Heide, Lars P.

Publication type:

Article